83 related articles for article (PubMed ID: 26490351)
1. Analyzing pathogenic (double-stranded (ds) DNA-specific) plasma cells via immunofluorescence microscopy.
Winter O; Musiol S; Schablowsky M; Cheng Q; Khodadadi L; Hiepe F
Arthritis Res Ther; 2015 Oct; 17():293. PubMed ID: 26490351
[TBL] [Abstract][Full Text] [Related]
2. T-bet-expressing B cells contribute to the autoreactive plasma cell pool in Lyn
Ottens K; Schneider J; Satterthwaite AB
Eur J Immunol; 2023 Aug; 53(8):e2250300. PubMed ID: 37134326
[TBL] [Abstract][Full Text] [Related]
3. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes.
Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L
Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814
[TBL] [Abstract][Full Text] [Related]
4. B-Cell and Monocyte Contribution to Systemic Lupus Erythematosus Identified by Cell-Type-Specific Differential Expression Analysis in RNA-Seq Data.
Dozmorov MG; Dominguez N; Bean K; Macwana SR; Roberts V; Glass E; James JA; Guthridge JM
Bioinform Biol Insights; 2015; 9(Suppl 3):11-9. PubMed ID: 26512198
[TBL] [Abstract][Full Text] [Related]
5. What is damaging the kidney in lupus nephritis?
Davidson A
Nat Rev Rheumatol; 2016 Mar; 12(3):143-53. PubMed ID: 26581344
[TBL] [Abstract][Full Text] [Related]
6. RNA sensing by conventional dendritic cells is central to the development of lupus nephritis.
Celhar T; Hopkins R; Thornhill SI; De Magalhaes R; Hwang SH; Lee HY; Yasuga H; Jones LA; Casco J; Lee B; Thamboo TP; Zhou XJ; Poidinger M; Connolly JE; Wakeland EK; Fairhurst AM
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):E6195-204. PubMed ID: 26512111
[TBL] [Abstract][Full Text] [Related]
7. T Cell Transcriptomes Describe Patient Subtypes in Systemic Lupus Erythematosus.
Bradley SJ; Suarez-Fueyo A; Moss DR; Kyttaris VC; Tsokos GC
PLoS One; 2015; 10(11):e0141171. PubMed ID: 26544975
[TBL] [Abstract][Full Text] [Related]
8. Remission in SLE: closing in on the target.
van Vollenhoven RF; Voskuyl A; Morand E; Aranow C
Ann Rheum Dis; 2015 Dec; 74(12):2103-6. PubMed ID: 26511997
[No Abstract] [Full Text] [Related]
9. The Role of Autophagy in Lupus Nephritis.
Wang L; Law HK
Int J Mol Sci; 2015 Oct; 16(10):25154-67. PubMed ID: 26506346
[TBL] [Abstract][Full Text] [Related]
10. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus.
Bentham J; Morris DL; Graham DSC; Pinder CL; Tombleson P; Behrens TW; Martín J; Fairfax BP; Knight JC; Chen L; Replogle J; Syvänen AC; Rönnblom L; Graham RR; Wither JE; Rioux JD; Alarcón-Riquelme ME; Vyse TJ
Nat Genet; 2015 Dec; 47(12):1457-1464. PubMed ID: 26502338
[TBL] [Abstract][Full Text] [Related]
11. Plasma cells as an innovative target in autoimmune disease with renal manifestations.
Hiepe F; Radbruch A
Nat Rev Nephrol; 2016 Apr; 12(4):232-40. PubMed ID: 26923204
[TBL] [Abstract][Full Text] [Related]
12. The Expression of BAFF Is Controlled by IRF Transcription Factors.
Sjöstrand M; Johansson A; Aqrawi L; Olsson T; Wahren-Herlenius M; Espinosa A
J Immunol; 2016 Jan; 196(1):91-6. PubMed ID: 26590315
[TBL] [Abstract][Full Text] [Related]
13. Sustained remission in lupus nephritis: still a hard road ahead.
Quintana LF; Jayne D
Nephrol Dial Transplant; 2016 Dec; 31(12):2011-2018. PubMed ID: 26590267
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.
Gottschalk TA; Tsantikos E; Hibbs ML
Front Immunol; 2015; 6():550. PubMed ID: 26579125
[TBL] [Abstract][Full Text] [Related]
15. Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
Steiman AJ; Gladman DD; Ibañez D; Noamani B; Landolt-Marticorena C; Urowitz MB; Wither JE
J Rheumatol; 2015 Dec; 42(12):2318-26. PubMed ID: 26568589
[TBL] [Abstract][Full Text] [Related]
16. Further thoughts about the ILLUMINATE studies of tabalumab in SLE.
Isenberg D
Ann Rheum Dis; 2016 Feb; 75(2):e11. PubMed ID: 26530320
[No Abstract] [Full Text] [Related]
17. Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices.
Hui-Yuen JS; Reddy A; Taylor J; Li X; Eichenfield AH; Bermudez LM; Starr AJ; Imundo LF; Buyon J; Furie RA; Kamen DL; Manzi S; Petri M; Ramsey-Goldman R; van Vollenhoven RF; Wallace DJ; Askanase A
J Rheumatol; 2015 Dec; 42(12):2288-95. PubMed ID: 26523030
[TBL] [Abstract][Full Text] [Related]
18. Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus.
Chu M; Wong CK; Cai Z; Dong J; Jiao D; Kam NW; Lam CW; Tam LS
Molecules; 2015 Oct; 20(10):19588-604. PubMed ID: 26516833
[TBL] [Abstract][Full Text] [Related]
19. Development and Pilot Testing of the Cutaneous Lupus Screening Tool.
Lam C; Liu SW; Townsend HB; Femia AN; Qureshi AA; Vleugels RA
JAMA Dermatol; 2016 Jan; 152(1):60-6. PubMed ID: 26509244
[TBL] [Abstract][Full Text] [Related]
20. Treatment of murine lupus with PD-LIg.
Zhou H; Xiong L; Wang Y; Ding L; Hu S; Zhao M; Zhou L
Clin Immunol; 2016 Jan; 162():1-8. PubMed ID: 26505305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
